News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks
Photo from Pashtoon Kasi/LinkedIn
Mar 26, 2024, 15:02

Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks

Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine shared on LinkedIn:

“We grossly underestimate how quickly immunotherapy can work. Especially with BOT/BAL (botensilimab) in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks. Unprecedented!

March is Colorectal Cancer Awareness Month.”

No alternative text description for this image

Proceed to the article.
Source: Pashtoon Kasi/LinkedIn

BOT/BAL botensilimab cancer colorectal cancer Colorectal Cancer Awareness Month immunotherapy for colorectal cancer NEST trial OncoDaily Oncology Pashtoon Kasi Weill Cornell Medicine
Special Coverage
Library
Feb 21, 2025, 16:41
New Paper Alert: Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach
Blog
Feb 21, 2025, 15:06
The full press release of ELLOK is out
Blog
Feb 21, 2025, 14:59
Siobhan Freeney: What women in Ireland need to know about Dense Breasts and Cancer
Blog
Feb 21, 2025, 14:54
CEO of the Canadian Cancer Society about the inequities in cancer care across populations in Canada - UICC
Career
Feb 21, 2025, 14:34
Kristiyana Kaneva is appointed as Medical Director of Oncology Early Development at AbbVie
Blog
Feb 21, 2025, 14:27
Douglas Flora: A Cure for Cancer - Closer Than We Think?
Blog
Feb 21, 2025, 14:26
14th Biennial Childhood Leukemia and Lymphoma Symposium: Advancing Research and Collaboration in Budapest
Blog
Feb 21, 2025, 14:13
Rachel Chown: An incredibly inspiring and humbling talk from Liubov Lisovska
Science
Feb 21, 2025, 14:08
Survival improvement of patients with melanoma brain or leptomeningeal metastases in Denmark - CCIT-DK
Science
Feb 21, 2025, 13:51
Aaron Sverdlov: Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities
Blog
Feb 21, 2025, 13:40
Breaking barriers: ensuring equal cancer care access for diverse communities - SPCC
Blog
Feb 21, 2025, 13:29
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society's SABCS